The RIES Forum concluded its tenth edition last Thursday on the island of A Toxa, establishing itself as a benchmark event for health, innovation, and public–private collaboration. Held at the Eurostars Isla de La Toja, the event brought together healthcare professionals, tech companies, public administrations, and universities to discuss the challenges and opportunities shaping the “medicine of tomorrow.”
In this setting, the RePo-SUDOE project showcased its platform for drug repurposing using molecular docking techniques. This tool enables the computational study of molecule–protein interactions, assessing the potential of existing drugs to act on new therapeutic targets.
RePo-SUDOE aims to accelerate the identification of new uses for existing medicines, leveraging computational methods to reduce the time and costs of traditional drug development.
Participation in RIES25 allowed the RePo-SUDOE consortium to share its progress and strengthen connections with other key players in the health innovation ecosystem, reaffirming its commitment to knowledge transfer and cross-border collaboration in the SUDOE area.